June 20, 2026 a 08:38 am

LH: Analysts Ratings - Labcorp Holdings Inc.

Historical Stock Grades

The latest data as of June 2026 shows a consistent positive outlook on Labcorp Holdings, with no recommendations for "Sell" or "Strong Sell". This demonstrates a strong confidence in the stock's performance from analysts.

Recommendation	Number	Score
Strong Buy	3
Buy	12
Hold	4
Sell	0
Strong Sell	0

Sentiment Development

Over recent months, the sentiment towards Labcorp Holdings Inc. has remained mostly optimistic, with stable "Buy" and "Strong Buy" ratings. However, a consistent minimal adjustment can be observed in the number of "Hold" recommendations, highlighting slight caution among analysts.

• Overall analyst ratings have remained stable with minor fluctuations.
• "Strong Buy" ratings have decreased slightly, indicating minor reservations.
• The continued absence of "Sell" forecasts suggests long-term confidence in Labcorp's stock.

Percentage Trends

The percentage distribution of analyst ratings over the past year highlights some key trends. There has been a moderate shift from "Strong Buy" to "Buy," signaling a slight reduction in strong bullish sentiment. While "Hold" ratings have seen a marginal uptick, analysts' overall confidence remains intact.

• Strong Buy decreased from 30% to 15%, suggesting conservative optimism.
• Buy has slightly increased, now constituting about 60% of recommendations.
• Hold ratings show minor increases, reflective of cautious market assessment.

Latest Analyst Recommendations

Recent analyst recommendations have shown a preference for maintaining existing recommendations, indicating a stable outlook for Labcorp Holdings Inc. The company's current standing in the healthcare domain continues to be viewed positively.

Date	New Recommendation	Last Recommendation	Publisher
2026-04-08	Outperform	Outperform	Evercore ISI Group
2026-02-24	Neutral	Neutral	Piper Sandler
2026-02-18	Overweight	Overweight	JP Morgan
2026-02-18	Outperform	Outperform	Baird
2026-02-06	Overweight	Overweight	JP Morgan

Analyst Recommendations with Change of Opinion

In the face of market dynamics, some analysts have adjusted their positions significantly, reflecting newfound confidence or caution. These changes can provide insights into the market's evolving perspective on Labcorp Holdings.

Date	New Recommendation	Last Recommendation	Publisher
2025-03-04	Buy	Neutral	Citigroup
2025-01-07	Outperform	In Line	Evercore ISI Group
2024-10-30	Buy	Hold	HSBC
2024-03-25	Buy	Hold	Argus Research
2022-12-12	Neutral	Buy	Citigroup

Interpretation

The broad consensus among analysts shows confidence in Labcorp's growth potential, with majority ratings skewing towards "Buy." However, the slight shift away from "Strong Buy" towards "Buy" and "Hold" indicates some caution, possibly in response to market trends or internal assessments. These movements suggest stable but cautious growth expectations, coupled with underlying market confidence sustaining the stock’s appeal.

Conclusion

Labcorp Holdings Inc. has continued to sustain robust analyst support, as evidenced by the favorable ratings trends over recent months. While the stock presents considerable potential for growth in the healthcare diagnostics sector, analysts appear to exhibit a cautious optimism. The reduction in "Strong Buy" ratings corresponds with the natural variability and the company's adaptation to industry conditions. The stock remains a solid choice within the diagnostic services sector, with analysts indicating stable but watchful confidence in its future trajectory.